Japanese Pharmaceutical Company's Red Quince Products Linked to Five Deaths and 114 Hospitalizations
In a shocking turn of events, five individuals have reportedly passed away after consuming health products from the Japanese pharmaceutical company, Small Pharmaceutical (hereafter referred to as Small Pharmaceutical). The company, based in Japan, has recently come under fire for their red quince-based health products, which have been linked to these fatalities. According to a report from the Japanese NHK, the company's CEO and other high-ranking officials held a press conference on March 28th, during which they expressed their condolences and apologized for the delay in providing information about the health issues associated with their red quince-based products. The company has since released a report detailing the problems associated with their red quince-based products, which have resulted in five deaths and 114 hospitalizations as of March 28th. The issue first came to light when the company acknowledged that five individuals had died after consuming their red quince-based health products. This number has since risen, with a total of five deaths and a reduction in hospitalizations from 106 to 93. The Japanese government is taking the matter seriously, with a cabinet meeting scheduled for March 29th to discuss the issue further. The health products in question were reportedly produced between April and October 2023, with the company releasing them onto the market between July and December of the same year.
29 March 2024
The Japanese government has set up a consultation hotline for concerned consumers and businesses, and has already recalled 4,350 units of the "Red Quince Cholesterol Tablets" product, with no reported recalls for the other two affected products. The controversy has sparked a heated debate on Chinese social media platform, Weibo, with users expressing their outrage and concern. One user wrote, "Is this a health product or a poison? Are you guys increasing the dosage too? This is ridiculous, one death a day, do you Japanese really dare to take these medicines?" Another user expressed their skepticism, stating, "So what if five people died?
Just apologize and move on." The safety of red quince as a medicinal ingredient has been called into question, with some experts suggesting that the addition of other substances may be to blame. Chen Hongbo, a professor of nephrology at the Zhejiang Provincial Hospital of Traditional Chinese Medicine, stated that red quince is generally safe and non-toxic when used in traditional Chinese medicine. However, the presence of other additives in the health products may be contributing to the health issues. The case of the five fatalities linked to Small Pharmaceutical's red quince-based health products serves as a stark reminder of the importance of proper regulation and oversight in the pharmaceutical industry. The company's apology and measures taken to address the issue are a step in the right direction, but more must be done to ensure the safety and well-being of consumers. As the investigation into the matter continues, it is essential that all relevant parties work together to identify the root cause of the problem and take appropriate action to prevent similar incidents from occurring in the future. The health and safety of consumers must always be the top priority, and it is the responsibility of companies and governments alike to ensure that this is upheld. In the meantime, those who have consumed the affected products are advised to seek medical attention if they experience any adverse health effects.
